Top compounds associated with response to MAEA


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib CTRPv2 pan-cancer AAC 0.014 0.7
mRNA azacitidine CTRPv2 pan-cancer AAC 0.014 0.7
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA Doxorubicin FIMM pan-cancer AAC 0.057 0.7
mRNA Vandetanib FIMM pan-cancer AAC -0.069 0.7
mRNA PHA-665752 GDSC1000 pan-cancer AAC 0.019 0.7
mRNA OSI-027 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA paclitaxel FIMM pan-cancer AAC 0.053 0.7
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.7
Download CSV